Tuesday's top biotech gainers include Regentis, which provided an update on its single-step knee repair implant; Eloxx, after getting uplisted to the Nasdaq; Alignment Healthcare, following recent corporate disclosures, including restricted stock unit (RSU) grants to executives; and Cartesian, which inked a strategic licensing deal with WestGene, among others. Read on… RGNT Walks the Talk Regentis Biomaterials Ltd. (RGNT), a tissue repair company focused on developing and commercializing an innovative hydro ...